Arctic® apples, Rainbow papaya & high oleic soybean oil for breakfast!

In one of the first times that Arctic® apples have ever been freely available for consumption since their recent approvals, this past weekend dried Arctic® apple slices were enjoyed alongside fellow biotech fruit Rainbow papaya, as well as blueberry muffins made with high oleic soybean oil! California Dietetic Association’s Annual Meeting took place in Riverside, CA April 9-11th, and included an educational breakfast and session hosted by Soy Connection, the United Soybean Board’s Health Professional Outreach Program. This event featured biotech crop experts Dr. Alan McHughen of UC Riverside and Gregory Jaffe from the Center for Science in the Public
Read More

The fascinating story of Rainbow papayas

Hawaii’s Rainbow papaya is one of the most unique crops out there, and one of the best biotech success stories as well. Plus, as the first commercially successful biotech fruit, it’s certainly of special interest to us at OSF. And, it’s not just us who find Rainbow papayas to be a fascinating story! Dr. Ania Wieczorek’s “Biotech in Focus” series, which we profiled last month, covered this very topic earlier this week in its latest bulletin, “Biotech Goes Local: GM Papaya in Hawaii”. Not only did Dr. Wieczorek do a great job summarizing both Rainbow papaya’s history and the science
Read More

Japan approves papaya produced through biotechnology

A few short months ago, a huge victory was won for biotechnology produced food worldwide. The Rainbow papaya, a variety enhanced through biotechnology to resist the ringspot virus, was approved for shipment to Japan. A chief factor that makes Japan’s approval of these papayas such big news is that this announcement marks the “first horticultural product, and the first direct-to-consumer food product to gain regulatory approval in Japan” (per this report from USDA Foreign Agricultural Service). Considering that the approval process began in 1999, this acceptance is a triumph that’s long overdue! This was not just a victory for biotech advocates,
Read More